首页> 外文期刊>Human Genetics >Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations
【24h】

Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations

机译:来自两个亚洲人群的帕金森氏病的非同义GIGYF2变异

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in the GIGYF2 gene at the PARK11 locus have recently been reported in Parkinson’s disease (PD). However, the pathogenicity of some of these mutations has been debated. We conducted a comprehensive genetic analysis of the entire GIGYF2 gene in a cohort of young onset and familial PD patients, followed up with screening of specific variants in a separate group of PD and healthy controls. A total of 850 study subjects [450 Parkinson’s disease (PD) patients and 400 controls] from two Asian countries were included. Our analysis revealed 17 variants distributed across the entire GIGYF2 gene. Ten of these were novel variants out of which eight were non-synonymous (all heterozygous). Out of these eight, half were novel polymorphic variants (0.2–2%) whereas four were novel non-synonymous variants which were not detected in healthy controls. The seven PD patients with non-synonymous variants had a mean age and age at onset of 55.3 and 50.9 years. All had typical features of PD and only one had a positive family history. The collective frequency of these non-synonymous variants was higher in PD compared to controls (1.6 vs. 0%, P = 0.016, relative risk 1.9, 95% CI 1.2, 1.9). None of the previously reported pathogenic mutations in Italian and French patients were present in our cohort. Our data suggest that GIGYF2 is unlikely to play a major role in our Asian populations. Rare non-synonymous variants appeared to be enriched in our PD patients compared to healthy controls. However, in vivo functional studies and segregation analysis in large pedigrees will be needed to determine if these single heterozygous variants represent rare mutations, risk alleles or benign polymorphisms.
机译:最近在帕金森氏病(PD)中报告了PARK11基因座上GIGYF2基因的突变。但是,其中一些突变的致病性已被争论。我们对一组年轻的发病和家族性PD患者进行了整个GIGYF2基因的全面遗传分析,随后在另一组PD和健康对照人群中筛选了特定的变异体。来自两个亚洲国家的850名研究对象(450名帕金森氏病(PD)患者和400名对照组)被纳入研究。我们的分析揭示了分布在整个GIGYF2基因上的17个变异体。这些中的十个是新颖的变体,其中八个是非同义的(都是杂合的)。在这八种中,有一半是新的多态变体(0.2–2%),而有四种是在健康对照中未检测到的新的非同义变体。 7名具有非同义变体的PD患者的平均年龄和发病年龄分别为55.3岁和50.9岁。所有患者均具有PD的典型特征,只有一个具有阳性家族史。与对照组相比,PD中这些非同义变体的总体频率更高(1.6比0%,P = 0.016,相对风险1.9,95%CI 1.2,1.9)。我们队列中没有先前报道的意大利和法国患者的致病突变。我们的数据表明,GIGYF2在我们的亚洲人口中不太可能发挥主要作用。与健康对照组相比,罕见的非同义变体似乎在我们的PD患者中得到了丰富。但是,需要进行大家族谱系的体内功能研究和分离分析,以确定这些单一的杂合变异体是否代表稀有突变,高风险等位基因或良性多态性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号